Loading organizations...
Loading organizations...
Biotechnology company developing therapies for rare bone diseases.
PreciThera has raised $28.7M across 1 funding round.
PreciThera has raised $28.7M in total across 1 funding round.
PreciThera has raised $28.7M in total across 1 funding round.
PreciThera's investors include Daniel O'Connell, CTI Life Sciences Fund, Nicola Urbani, Pierre Beauparlant.
PreciThera has raised $28.7M across 1 funding round. Most recently, it raised $28.7M Series A in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 27, 2017 | $28.7M Series A | Daniel O'Connell, CTI Life Sciences Fund, Nicola Urbani, Pierre Beauparlant |